Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma ; volume:98 ; number:S 02 ; year:2019 ; 02
Konferenz: Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde; 2019-05-29; Estrel Congress Center Berlin; Deutsche Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn
Laryngo-Rhino-Otologie ; 98, Heft S 02 (2019), 02
- Beteiligte Personen und Organisationen
-
Hein, M.
Flechsig, P.
Lippert, BM
Bulut, OC
- DOI
-
10.1055/s-0039-1686849
- URN
-
urn:nbn:de:101:1-2019092315521698185995
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hein, M.
- Flechsig, P.
- Lippert, BM
- Bulut, OC
Ähnliche Objekte (12)
Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma